Sellas Life Sciences Group Inc (NASDAQ:SLS)

1.25
Delayed Data
As of 3:59pm ET
 +0.07 / +5.93%
Today’s Change
1.17
Today|||52-Week Range
7.37
-47.03%
Year-to-Date
No recent news for Sellas Life Sciences Group Inc.

Today’s Trading

Previous close1.18
Today’s open1.20
Day’s range1.20 - 1.27
Volume11,610
Average volume (3 months)352,063
Market cap$36.2M
Data as of 3:59pm ET, 03/29/2023

Growth & Valuation

Earnings growth (last year)-59.27%
Earnings growth (this year)+67.92%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-86.84%
P/E ratioNM
Price/Sales45.77
Price/Book5.54

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc0.000.00%
----
NYMXNymox Pharmaceutical...-0.06-15.03%
OCXOncoCyte Corp+0.02+5.52%
Data as of 3:59pm ET, 03/29/2023

Financials

Next reporting dateMay 17, 2023
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$1.0M
Annual profit (last year)-$41.3M
Net profit margin-4,130.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts